In the ever-evolving field of anesthesia, new research constantly reshapes how we approach patient care. In this episode, we explore the compelling findings of a recent systematic review and meta-analysis on the impact of propofol-based total intravenous anesthesia (TIVA) on cancer outcomes.

Here’s some of what we discuss in this episode:

• We’ll provide an overview of the study and some of the key findings.
• The biological underpinnings of propofol’s benefits.
• The preservation of immune function could be a key factor in why propofol is associated with better survival outcomes.
• Dissecting the findings on recurrence-free survival.
• A deep dive into propofol’s role in lung cancer.
• Clinical implications and practical considerations.
• The future of anesthesia and cancer research.

Visit us online: https://beyondthemaskpodcast.com/

The 1099 CRNA Institute: https://aana.com/1099

***Use coupon code BEYOND1999 to get 20% off through November 2024

Get the CE Certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf

Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246

Donate to Our Heart Your Hands here: https://www.ourheartsyourhands.org/donate

Support Team Emma Kate: https://grouprev.com/haloswalk2024-shannon-shannon-brekken